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ABSTRACT
Objective: Retrospective analysis of surgico-pathologic
data comparing total laparoscopic hysterectomy (TLH)
with total abdominal hysterectomy (TAH) patients with
uterine neoplasia
Methods: We conducted a chart abstraction of all patients
undergoing hysterectomy for uterine neoplasia from Sep-
tember 1996 to November 2004. Patients were assigned to
undergo the abdominal or laparoscopic approach based
on established clinical safety criteria.
Results: The study included 105 patients, 29 with TAH
and 76 with TLH. TAH patients were older (68 vs. 61,
P0.021); however, both groups had similar body mass
indexes (31) and parities (1.6). Controlling for age, surgi-
cal duration was similar (152 minutes). Average blood loss
was higher for TAH, (504 vs.138 mL, P0.001). Hospital
stays were significantly longer for patients with TAH than
for those with TLH (5.4 vs. 1.8 days, P0.0001). Uterine
weight was greater (197 vs. 135 g, P0.008) and myome-
trial invasion deeper in the TAH group (48% outer half vs.
17%, P0.001). More patients had Stage II or higher dis-
ease in the TAH group (35% vs. 17%, P0.038). More TAH
patients needed node dissection (79% vs. 28%, P.001).
Node yields from dissections of 23 TAH cases and 21
laparoscopic cases were similar (17 nodes). Total and
reoperative complications from TAH versus TLH were not
statistically different in our small sample (14.3 vs. 5.2%
total, NS; 10.3 vs. 2.6% reoperative). One conversion was
necessary from laparoscopy to laparotomy for unsus-
pected bulky metastatic disease.
Conclusion: Based on clinical selection criteria, TLH per-
formed for endometrial pathology has few complications
and is well tolerated by select patients. The advantages are
less blood loss and a shorter length of hospital stay for
qualified patients.
Key Words: Total laparoscopic hysterectomy, Total ab-
dominal hysterectomy, Uterine neoplasia.
INTRODUCTION
Traditional therapy for uterine hyperplasia, carcinoma, or
sarcoma includes total abdominal hysterectomy (TAH)
with salpingo-oophorectomy, and when pathologic stage
is higher than IB or tumor grade is 3, lymph node sam-
pling is performed.1 In 1993, laparoscopic-assisted vaginal
hysterectomy (LAVH) with indicated node dissection was
described as an alternative to TAH for clinical stage I
endometrial cancer patients.2 LAVH has also been shown
to be appropriate for women over the age of 75 with
endometrial cancer, conferring a similar blood loss, equal
or higher node counts, longer operating times, shorter
hospital stays, and less pain than TAH.3,4 In randomized
trials comparing TAH versus LAVH for benign indications,
similar overall complications, less blood loss, longer op-
erating times, fewer transfusions, less pain, and shorter
hospital stay and disability were observed with LAVH.5–9
However, LAVH is predicated upon the ability to dissect
the cervix and lower uterine segment through the vagina.
Obesity, nulliparity, and senior age, the 3 most common
risk factors for endometrial cancer, may all contribute to
making the vagina longer, narrower, and thus it is more
difficult to complete the vaginal portion of the LAVH.
Many obese, senior, and nulligravid women will not qual-
ify for the LAVH because they lack sufficient uterine pro-
lapse or vaginal capacity.
The total laparoscopic hysterectomy (TLH) has been de-
scribed over the last 10 years as potentially quicker, more
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SCIENTIFIC PAPERefficient, and associated with less blood loss than
LAVH.10,11 In 2003, we reported our TLH data from a series
of patients and observed it to be safe in the care of obese
patients with pelvic masses and early ovarian carcinoma.12
It is also more available to nulliparous women13 and
senior women.14 Although a randomized clinical trial
would be the standard for confirming the indications,
safety, efficacy, and complication rates of TLH in women
with endometrial neoplasia, as yet, no large cohort re-
views of TLH procedures have been conducted for this
indication to serve as pilot data.
This retrospective, nonrandomized cohort review delin-
eates the surgical and pathological findings of a clinical
series of all patients with early endometrial cancer, hyper-
plasia, or sarcoma in a private practice in which over 611
TLHs have been performed. The standard in this practice
is to assign patients to TLH or TAH based on evaluation of
the medical history, physical examination, and clinical
testing, with specific documentation of severe adhesions
from prior surgeries, a large uterus (250 g) confirmed by
ultrasound, or significant chronic obstructive pulmonary
disease (COPD). The objective of this retrospective cohort
analysis was to generate pilot data that confirm the safety
of this selective approach to assigning the appropriate
surgical method.
METHODS
Study Design
Chart abstraction with Investigational Review Board ap-
proval was undertaken for all cases of hysterectomy per-
formed by 1 attending surgeon from September 5, 1996 to
November 15, 2004, at 4 San Francisco Bay area hospitals
for patients with clinically localized, pathologically con-
firmed, endometrial carcinoma, hyperplasia, or sarcoma.
The names were obtained by searching the computer
billing data for Current Procedural Terminology (CPT)
code diagnoses 621.3, 179.0, and 182.0. Women with
metastatic disease by clinical or radiographic assessment
were not included in this retrospective study. At the time
of their initial presentation, patients were assigned to an
abdominal approach if they had any of the following:
documentation of severe adhesions from a prior operative
report, a large uterus that would not fit through the vagina
without morcellation, or significant COPD that precluded
a 45-degree Trendelenburg position. Patient’s weight,
height, (body mass index) BMI, and age were not consid-
erations in selection of the approach, because both BMI
and age have previously been shown to not impact out-
comes of TLH.12,14 COPD was defined as any history of
severe asthma or moderate to severe pulmonary obstruc-
tive disease considered poorly controlled. All other
women were assigned to undergo a laparoscopic ap-
proach.
Surgical Approaches
All patients received general anesthesia and standard pro-
phylactic cephalosporin antibiotic, a subcutaneous injec-
tion of an antithrombin agent, and wore sequential com-
pression devices on their upper and lower legs.
TAH is defined as an abdominal hysterectomy with a
10-cm to 15-cm vertical incision in the abdominal wall,
through which the standard operation is carried out.15
Patients usually require a 3-day to 5-day hospitalization,
followed by a 6-week recovery time.
For both approaches, all uteri with grade 1 and 2 carci-
nomas were given to the pathologist for frozen section
examination for indicators of lymph node sampling: cer-
vical invasion, deep myometrial invasion, or lymphatic
space invasion. Pelvic and aortic nodes were also dis-
sected whenever patients had grade 3 carcinoma. The
pelvic lymph node dissection consists of resecting the
fibro-fatty lymph-bearing tissue from the genitofemoral
nerve medially, over the external iliac artery and vein
down to the crossing of the deep circumflex iliac vein over
the external iliac artery, including the tissue around the
internal iliac artery, anterior and medial to the obturator
nerve, and lateral to the superior vesical artery and ureter.
Aortic node dissections included the fibro-fatty node-
bearing tissue anterior to the vena cava, the aorta, and to
the left of the aorta from the ureters up to the inferior
mesenteric artery.
The term “TLH” means all surgery was performed entirely
through the laparoscopic ports.16 Because this is a rela-
tively new application of surgical technique in gyneco-
logic oncology, the specific steps will be delineated: the
patient is positioned in a modified lithotomy position with
the hips at about a 180-degree extension and the knees
flexed at nearly 90 degrees, with the table tilted nearly
45-degrees Trendelenburg. The arms are tucked along the
patient’s side and secured in a sled, and large gel or foam
bolsters are taped to the table above the shoulders to
prevent sliding on the table. After injecting the umbilical
apex with Marcaine, towel clips are used to elevate the
abdominal wall, and a bladed 5-mm EndoEthicon trocar is
inserted vertically without preinsufflation.17 After insuffla-
tion with CO2 to 12 mm Hg, 3 additional 5-mm ports are
inserted under direct visualization, 1 suprapubic and 2
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perior iliac crests.
The abdominal inspection and cytologic washing are per-
formed before inserting the Humi Uterine Manipulator
(CooperSurgical, Inc. Trumbull, CT) through the cervix.
All adhesions are lysed, and any peritoneal lesions are
biopsied or excised before the hysterectomy. Once the
ureters are identified through the peritoneum at the pelvic
brim, the infundibulopelvic ligaments are cauterized with
bipolar cautery and incised with the 5-mm LCS Harmonic
scalpel (Ethicon Endo-Surgery, Cincinnati, OH).18 Then,
the broad and round ligaments are incised with the Har-
monic scalpel. To replicate the effects of “traction-
counter-traction,” to facilitate parametrial dissection, the
uterus is placed under tense axial elevation by pushing
the uterine manipulator directly cephalad. The bladder
flap is opened and incised with the Harmonic scalpel
exposing the anterior cervical fascia. From this point to the
incising into the vagina, the cervico-vaginal margin is
repeatedly, carefully confirmed by using instrument “pal-
pation” of the firmer cervix stroma, which moves together
as a solid mass, compared with the more pliant upper
lateral vagina that dimples easily. Also, the surface of the
cervix anteriorly and posteriorly are frequently visualized
and palpated with the instruments to replace the usual
open palpation of the cervico-vaginal margin by the fin-
gers. If it is difficult to identify the precise cervico-vaginal
margin, a right angle retractor or ribbon can be passed
into the vagina anterior to the uterine manipulator to
identify the junction anteriorly so that the Harmonic scal-
pel can by used to puncture into the vagina at 12 o’clock.
The uterine arteries are then skeletonized and extensively
cauterized at the junction of the lower and middle third of
the cervical body by using the bipolar cautery, and incised
with the Harmonic scalpel directly through to the glisten-
ing white, smooth cervical fascia beneath. The arterial
pedicle is pushed inferiorly exposing the cardinal liga-
ment fibers. These are incised in 3 bundles, anteriorly,
then posteriorly to include the uterosacral ligament, and
lastly medially and inferiorly. This last incision usually
identifies the exact edge of the cervico-vaginal margin and
allows for the next medial bite to pierce into the vagina at
either 9 o’clock or 3 o’clock. Entry into the vagina is
confirmed by rapid loss of pneumoperitoneum. The uter-
ine manipulator is then removed and a folded glove con-
taining 2 dry, fluffed 4x4-inch gauze is placed in the
vagina to maintain the pneumoperitoneum. With direct
exposure of the cervical os by using toothed biopsy for-
ceps as graspers on the vagina and the cervical edge, it is
possible to expose and incise along the precise margin
between the cervix and vagina. Once the entire cervix is
cut away from the vagina, a tenaculum is inserted through
the vagina, beside the glove, to grasp the cervix and
deliver the tissue out of the vagina. The uterus is submit-
ted for frozen section.
If node dissection is not indicated, the vaginal apex is
closed by using toothed biopsy forceps as graspers and #1
Vicryl laparoscopic suture (JK-10 Endo Ethicon) with an
ST-3 needle in 3 or more figure-eight (technically spiral)
sutures made with a Wolfe or Ethicon needle driver, fixing
the vaginal angle to the proximal-most uterosacral liga-
ments for suspension.
Patients are given printed information about their bowel
preparation, and their inpatient postoperative and home
recovery. Discharge instructions recommend resumption
of all activities as soon as tolerable, and early ambulation
and resumption of floor exercise is encouraged. Patients
are instructed not to engage in any vaginal penetration
until after their 6-week vaginal checkup. All patients are
seen postoperatively for an abdominal incision check at
10 days and again at 6 weeks. Patients are referred for
radiation if they have a grade 3 cancer with any invasion,
lymphatic channel invasion, or Stage Ic or higher.19
Data Management and Analysis
Office and hospital charts were then reviewed for patient
data regarding age, height, weight, parity, preoperative
diagnosis, procedure(s), estimated blood loss (EBL), du-
ration of surgery, duration of hospital stay, pathologic data
including uterine dimensions, weight, cancer characteris-
tics like depth of invasion, grade, presence or absence of
lymph-vascular invasion, cervical invasion, pelvic cyto-
logic washings, number of nodes dissected, and compli-
cations. The data were analyzed with SPSS statistical anal-
ysis software, with ANOVA and the t test used for
comparison of continuous data, and chi-square analyses
including Fisher’s exact test for nominal data. A value of
P0.05 was accepted as significant.
RESULTS
Of the 105 patients with endometrial pathology, 76 qual-
ified for TLH, and 29 underwent TAH. Patients had a
significantly higher mean age in the TAH group, (68 vs. 61
years, P0.021) (Table 1). No significant differences ex-
isted in height, weight, body mass index (BMI), or parity.
Therefore, the surgico-pathological analyses that would
be affected by age were done controlling for age.
Most women had a diagnosis of endometrial carcinoma
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operatively (81%). The TAH group had more cases of
endometrial carcinoma than did the TLH group both by
preoperative biopsy assessment (97% vs. 79%, P0.036),
and by postoperative final pathology (97% vs. 78%,
P0.021). One patient in each group had complete stag-
ing for a pelvic mass and was later confirmed to have 2
primaries: Stage Ia endometrial carcinoma and Stage Ia
ovarian carcinoma. Two patients were found to have a
sarcoma, a Stage Ic low-grade sarcoma, and a stage Ia
high-grade stromal sarcoma (Table 2).
In Table 3, the surgical data are stratified by approach,
adjusting the means for age. The mean durations of sur-
gery for abdominal and laparoscopic approaches were
similar (154 min). Blood loss was higher in the TAH group
(504 mL vs. 138 mL,P 0.001), and transfusions were
more common (0.69 units/patient vs. 0.04, P0.001).
Length of hospital stay was longer for TAH than for TLH
(5.4 days vs. 1.8 days, P0.0001).
In Table 4, the pathological data are stratified by ap-
proach. Uterine sizes were larger in the abdominal ap-
proach groups by width (P0.018), depth (P0.041), and
weight (P0.008), but not length. TAH cases were more
likely to have outer third myometrial invasion (48% vs.
17%, P0.001), but TLH cases had more superficial or
noninvasive tumors (28% vs 68%, P0.001). Tumor grade
and incidence of cervical invasion or peritoneal fluid
spread were similar in both approaches, but a higher
incidence of lymph vascular space invasion (LVSI) (38%
vs. 17%, P0.036) occurred in the TAH group. More
patients with 1998 FIGO stage II or higher were assigned
to the TAH group (35% vs. 17, P0.038). TAH group
patients were more likely to have a node dissection indi-
cated by virulence factors (79% vs. 28%, P0.001); how-
ever, the lymph node yields were similar (P0.810): 16.3
nodes by laparotomy (range, 2 to 45) and 18.0 nodes by
laparoscopy (range, 4 to 56).
No significant difference existed in total complication
rates for the abdominal or laparoscopic groups (14% vs.
5%, P0.111) or in reoperative complication rates (10 vs.
3%, P0.128) (Table 5). Four complications occurred in
the TAH group: 2 cases of wound dehiscence and 1 case
of postoperative hemorrhage requiring reoperation, and 1
case of postoperative wound infection treated with pack-
ing. Among the TLH cases, 1 case each of trocar site
herniation and small-bowel adhesions to the vaginal cuff
causing small-bowel obstruction required reoperation.
One patient had prolonged diverticulitis after her TLH,
and one had vaginal cuff dehiscence, both resolving with
expectant management. One TLH patient was converted
to open laparotomy when bulky metastatic lesions were
identified in the nodes, and on the peritoneal surfaces.
DISCUSSION
This study documents a series of patients with clinically
early uterine neoplasia assigned by clinical safety param-
Table 1.
Patient Demographics (ANOVA)
Open n29,
mean (SD)
Laparoscopic
n76, mean (SD)
P Value
Age (y) 67.6 (13.0) 60.9 (13.1) 0.021
Parity 1.8 (1.4) 1.6 (1.4) 0.426
Height (inches) 63.8 (2.8) 64.0 (2.7) 0.738
Weight (lbs) 184.8 (74.3) 176.5 (48.5) 0.580
Body Mass Index 31.9 (12.7) 30.5 (8.9) 0.583
Table 2.
Patient Diagnoses (Fisher’s Exact Test)
Open
n29, N(%)
Laparoscopic
n76, N(%)
P Value
Preoperative Diagnosis 0.036
Atypical endometrial
hyperplasia
1 (3) 16 (21)
Endometrial carcinoma 28 (97) 60 (79)
Postoperative Diagnosis 0.021
Noninvasive sarcoma,
or hyperplasia
1 (3) 17 (22)
Invasive carcinoma,
or sarcoma
28 (97) 59 (78)
Table 3.
Surgical Data by Approach (ANOVA)
Open n29,
M*(SD)
Laparoscopic
n76, M*(SD)
P Value
Duration of surgery
(min.)
143 (52.6) 158 (48.9) 0.783
Blood loss (mL) 504 (333.3) 138 (157.3) 0.001
Transfusions (units/pt) 0.60 (1.3) 0.04 (0.6) 0.001
Length of hospital stay
(days)
5.4 (3.2) 1.8 (1.1) 0.0001
*Mean adjusted for age.
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on the results of this series, TLH can be recommended for
randomized clinical trials as a potentially safe alternative
to TAH for many women, with no increased morbidity.
Obese, elderly, and nulliparous women have a higher20–22
incidence of uterine carcinoma in comparison with others.
Although we did not use BMI, age, or parity in the assign-
ment of surgical approach, historically, obesity and senior
age have been seen by some as a relative contraindica-
tions to a laparoscopic approach.23 Obese patients sustain
more blood loss and more incisional and infectious com-
plications from laparotomy and may incur significant
potential benefit from a laparoscopic approach.24–26
Although obese women can tolerate increased intraperi-
toneal pressure well if they have normal cardiac func-
tion,27 respiratory mechanics can be adversely affected for
the duration of the pneumoperitoneum.28 In particular,
obese women often need higher than usual inspiratory
pressures in the Trendelenburg position, because the
weight of the abdominal wall, bowel, and omentum on
the diaphragm reduces ventilatory compliance during sur-
gery.29 Peritoneal insufflation has also been shown to
cause a significant reduction in cardiac output, increases
in mean arterial pressure and pulmonary vascular resis-
tance, demonstrating that senior patients with COPD are
not candidates for a laparoscopic approach.30 In one se-
ries, a higher risk of conversion to open laparotomy was
observed with increasing BMI over 30. In our entire series
of laparoscopic hysterectomies reported elsewhere,13
which now totals over 611, we have not observed higher
complications, blood loss, surgical durations, hospital
Table 4.
Pathologic Data by Approach
Open n29,
M*(SD)
Laparoscopic
n76, M*(SD)
P Value
Size of Uterus
Length (cm) 9.2 (2.1) 8.7 (2.2) 0.338
Width (cm) 6.9 (1.8) 5.9 (1.9) 0.008
Depth (cm) 4.8 (2.1) 4.2 (1.3) 0.041
Weight (g) 197 (138.5) 135 (80.3) 0.008
Depth of Myoinvasion 0.001
Noninvasive or
superficial
8 (28) 52 (68)
Inner 50% 7 (24) 11 (15)
Outer 50% 14 (48) 13 (17)
Grade of Lesion* 0.066
Atypical hyperplasia 1 (3) 15 (20)
Well differentiated 11 (38) 34 (45)
Moderately differentiated 8 (28) 17 (22)
Poorly differentiated 9 (31) 8 (11)
Sarcoma 0 2 (3)
Cervical Involvement 0.750
Present 4 (14) 9 (12)
Absent 25 (86) 67 (88)
Lymph Vascular Space
Invasion
0.036
Absent 18 (62) 63 (83)
Present 11 (38) 13 (17)
Cytologic Washing 0.550
Negative 21 (78) 61 (85)
Positive 6 (22) 11 (15)
FIGO Stage 1998 0.038
O (Hyperplasia) 1 (3) 15 (20)
IA 7 28
IB 10 18 (62) 14 48 (63)
IC 1 6
II or higher 10 (35) 13 (17)
No. of Patients Having
Node Dissection
23 (79%) 21 (28%) 0.001
No. of Nodes Obtained 16.3 (10.6) 18.0 (13.4) 0.810
*Mean adjusted for age.
Table 5.
Complications by Approach (Fisher’s Exact Test)
Complication Open
n29,
N(%)
Laparoscopic
n76,
N(%)
P Value
None 25 (86) 72 (95)
Diverticulitis 0 1 (1.3)
Abdominal wound dehiscence 2 (7) 1 (1.3)
Peritoneal vaginal dehiscence 0 1 (1.3)
Postoperative bowel
obstruction
0 1 (1.3)
Postoperative wound infection 1 (3.5) 0
Postoperative hemorrhage 1 (3.5) 0
No. Reoperative
complications
3 (10.3) 2 (2.6) 0.128
Total complications 4 (14.3) 4 (5.2) 0.111
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age, or cardiorespiratory problems. In this uterine neopla-
sia series, 56/105 (53%) of our TLH patients had BMI over
30 with no increase in complications. Our heaviest patient
weighed 331lbs, with a BMI of 60, and sustained a 50cc
operative blood loss, taking 90 minutes to complete, and
was discharged the day after surgery.
Senior women have been observed to benefit from a
laparoscopic approach in multiple gynecologic cancer
sites.24,31 Age has not been seen as a contraindication for
laparoscopic lymphadenectomies for endometrial can-
cers.32 We have previously reported our series of total
laparoscopic hysterectomies for women with oncologic
problems stratifying our outcomes by age,14 showing no
increase in rate of complications, surgical durations, vol-
ume of blood loss, or hospital stays. Twenty of 76 (26%)
women in this laparoscopic series were over age 70, with
the eldest being 90. All but 4 of these 20 patients were
discharged within 2 days of surgery. None required con-
version to laparotomy, but one had trocar-site herniation.
In both treatment groups in this study, 39% of the patients
were nulliparous. Although LAVH has been reported for
treatment of women with endometrial carcinoma,33 many
nulliparous women, lacking descensus, will still require
open laparotomy or risk conversion to laparotomy when
the vaginal dissection becomes impossible.34 Because all
of the dissections in the TLH are performed abdominally
via a laparoscopic approach, this procedure is available
for women with no descensus or who have long, narrow
vaginas. We believe that if surgeons learn to perform
hysterectomy entirely via laparoscopes, morbidity from
hysterectomy would be reduced. In addition, avoiding
any vaginal approach, even among women with adequate
descensus or vaginal capacity, may also reduce the risk of
subsequent urinary incontinence and vault prolapse, both
of which are seen more often after vaginal hysterectomies
than after laparotomy hysterectomies.35–37
Many are concerned that significantly longer operating
times are necessary with any laparoscopic approach, es-
pecially with LAVH;38 however, shorter endoscopic oper-
ating times have been reported with greater laparoscopic
surgical experience39,40 and with a total laparoscopic ap-
proach when compared with LAVH.11,41 Our data support
this, showing no difference in operating times between
our TLH and TAH groups, which persists even when all
patients having node dissection are excluded (154 min vs.
138 minutes, P0.535).
As expected, we observed a lower mean blood loss and
fewer transfusions with TLH; however, this information
should be tempered with the observation that women
undergoing abdominal approaches had significantly
larger uteri than women having laparoscopic approaches.
Our TLH blood losses have decreased over time. From the
20 most recent laparoscopic cases, 13 patients lost under
100 mL, with 9 of these patients undergoing node dissec-
tions.
The shorter median and mean hospital stay for the TLH
patients (mean, 5.4 days vs. 1.8 days, P0.001) is similar
to observations by others.38,42–44 Currently, we discharge
patients in the afternoon of postoperative day 1 even if
they require a node dissection. From the 20 most recent
TLH cases, with 9 of these patients undergoing node
dissections, 19 went home the first day after surgery.
The TAH group also had significantly larger uteri, deeper
myoinvasion, more lymphatic channel invasion and a
trend to higher grade; thus, significantly more lymph node
dissections. This may also relate to the fact that the TAH
patients were older, as senior women with endometrial
cancers have been shown to have more aggressive dis-
ease.21 Women with larger uteri may have had more
progression of their disease before diagnosis and thus be
assigned to open approach more often.
Laparoscopic lymph node dissections were equally pro-
ductive in both approaches. Prior reports from this cohort
have confirmed that node dissections were not more com-
plicated in senior or obese women compared with node
dissections in younger or more ideal-weight patients.13,14
Laparoscopic node dissections are generally easier and
incur less blood loss because the vasa vasorum are much
more clearly seen and clipped. In fact, we analyzed blood
loss in TLH cases with and without node dissection and
found no difference (148 vs. 124 mL, P0.841).
Peritoneal cytology was positive in similar proportions of
both groups (22% vs. 15%), and roughly similar to other
reports of 11% in clinically early stage series.45 Some of
our patients had undergone hysteroscopy before referral
to our oncology service, which may have contributed to
risk of peritoneal cytology positivity46–49 and obscured
finding natural differences in tumor virulence. Unfortu-
nately, we did not collect data on the use of preoperative
hysteroscopy to analyze the effects of this procedure.
Recent reports have associated LAVH with a higher risk of
positive cytology, possibly because of excessive uterine
manipulation during the procedure extruding malignant
cells out through the fallopian tubes.50 In our practice, we
minimize risks of iatrogenic peritoneal positivity by
strongly discouraging the use of diagnostic hysteroscopy
among our referral base unless uterine cancer has been
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until after coagulating the tubes, and we use only gentle
and minimal manipulation of the uterus.
The rate of urologic complications seen so often in pa-
tients undergoing LAVH or TLH was surprisingly not seen
in this series, although other patients in the surgical prac-
tice of the authors have sustained urologic injuries, which
are reported elsewhere.12 Currently, after completing 611
TLHs for all gynecologic indications, 15 patients (2.5%)
sustained a urologic injury, with 7 (1.2%) undergoing
recognition and immediate repair (4 cystotomy repairs
and 2 ureteroureterostomies), and 8 (1.3%) requiring re-
operation (4 ureteral stents, and 4 ureteroneocystoto-
mies). All but 2 of the urologic injuries occurred during the
first two thirds of cases. We attribute the decreasing rate of
urologic injuries in this series to the learning curve and to
our method of dissection of the cardinal ligament pre-
cisely on the cervical fascia, with rigorous use of traction-
counter-traction, and frequent palpatory and visual reap-
praisal of the cervico-vaginal anatomy.
No port-site recurrences were noted, but 1 patient had a
vaginal cuff recurrence and is disease free after radiation.
Although 2 patients developed wound dehiscence in the
TAH group, 1 TLH patient herniated her small bowel
through a 5-mm trocar site, and all required reoperation.51
Vaginal dehiscence developed in another patient after
sexual penetration at 6 weeks, which healed without re-
operation.52
Limitations of the Study
Many serious challenges exist to the utility and validity of
comparing these 2 groups of patients in a single practice,
most having to do with the initial nonrandom, clinically
based assignment of approach. Such selection bias does
significantly mimic clinical practice standards, offering im-
plications for surgeons in practice, but this selection bias
also hinders the broader utility of these data except as a
pilot series. In the absence of the randomized clinical trials
confirming any guidelines for assignment of approach,
our conservative pattern of assignment was entirely clin-
ically based: pulmonary disease, metastatic disease, doc-
umented severe adhesions, or a measurably large uter-
us,30,53,54 but randomized clinical trials are now needed
and indicated.
The nonrandom assignment to approach is also the most
probable cause of the age disparity observed between the
patients undergoing the 2 approaches. Older women are
more likely to have had more surgeries, developed pul-
monary disease, and to be at risk for postoperative med-
ical complications.24,55 No difference existed, however, in
their height, weight, or BMI. Age is not normally a limiting
factor for laparoscopic approaches,14 but pulmonary func-
tion must be grossly normal or evaluated and cleared
preoperatively.24
The nonrandom assignment criteria for surgical approach
are likely also responsible for the observation of TAH
group patients having larger uteri, deeper myoinvasion,
higher stage, and trend of higher grade, and thus more
node dissections. Elderly women have been shown to
have more aggressive carcinomas.1 However, the lymph
node yields were similar in both approaches, and similar
to yields previously reported for either laparotomy or
laparoscopy.31,39,40,42,44,56
Another of the initial assignment criteria, that the uterus
not be overly enlarged precluding its removal per vagina
without morcellation, also contributes to the observation
of larger uterine size in the laparotomy group and may
predispose to larger, more invasive lesions. This criterion
was initially important because of the concern about spill-
age of cancer cells into the peritoneum with morcellation
of a large, cancerous uterus. Recently, we have obviated
that concern in multiparous women to some degree by
using a Lapsac (Cook Surgical, Chicago, IL) ripstop nylon
5x8-inch sack with a purse string. The sack is passed
through the 10-mm umbilical trocar, encasing the uterus
with the cervix pointing toward the open end, and passed
out of the vagina, draw string first, allowing morcellation
of the uterus from within the sack, with no peritoneal
spillage. This technique is not possible when the vagina is
narrow and long.
The laparoscopic techniques used and described above
roughly parallel that of the traditional open technique
(except the morcellation), making the procedure more
easily learned by abdominal gynecologic surgeons. One
can safely obtain experience and practice the technique
during open surgery by performing the entire open lapa-
rotomy hysterectomy with the CS Harmonic scalpel,
which is the hand-held, shorter version of the 5-mm lapa-
roscopic LCS Harmonic scalpel, designed for open proce-
dures. Other safety procedures, similar in both the open
and laparoscopic, and familiar to every gynecologic sur-
geon, include frequent identification of the ureters, con-
stant traction-counter-traction to separate the uterine ar-
teries from the ureters with constant upward axial
pressure on the uterine manipulator, and frequent palpa-
tory identification of the cervical and parametrial anat-
omy. The last limitation is the great variability of surgeons’
experience at laparoscopic surgery and ability to convert
JSLS (2005)9:277–286 283their open skills to laparoscopic skills. We recommend
that surgeons learning these techniques should work with
other attending surgeons in their early series, because
residents are not typically able to prevent complications
when they are also learning these techniques.
We are hopeful that these data will serve to justify pro-
spective, randomized clinical trials. The series exposes
difficulties, highlights risks that need to be minimized, and
confirms the safety of the procedure, which will be im-
portant in designing randomized trials. Taking into ac-
count concerns about the assignment to approach and the
disparities in age, comparison of data from the 2 different
approaches is still very useful and mimics actual clinical
practice standards.
Gynecologic oncologists do not randomly assign a surgi-
cal approach. Rather, they evaluate each patient’s surgical
and medical history, physical examination, and radiolog-
ical testing data to determine the safest and most feasible
approach. They also perform additional procedures to
address pelvic floor dysfunction and anomalous findings
as needed. This series reflects just that standard, docu-
ments the surgical difficulties and clinical utility of each
approach, and illuminates the need for study in prospec-
tive randomized trials.
CONCLUSION
We report this retrospective, observational series of total
laparoscopic hysterectomies and total abdominal hyster-
ectomies to document the safety and reasonable surgical
parameters so that more surgeons will undertake a total
laparoscopic approach for their patients with endometrial
pathology when safely indicated. Given that a laparo-
scopic approach can never be recommended for all
women with clinically early endometrial cancer due to the
previously mentioned contraindications, selective assign-
ment of approach will always be needed. The data gen-
erated from this series, which demonstrate the feasibility,
benefits, and utility for select patients in real clinical prac-
tice, should serve as a basis for conducting future random-
ized clinical trials.
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